December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Melatonin Analogues Modulate Rabbit Intraocular Pressure
Author Affiliations & Notes
  • JJ Pintor
    Bioquimica E U Optica Universidad Compluten Madrid Spain
  • T Pelaez
    Bioquimica E U Optica Universidad Compluten Madrid Spain
  • CH V Hoyle
    Dep Anat Develop Biol UCL London United Kingdom
  • A Peral
    Optica E U Optica Universidad Complutens Madrid Spain
  • Footnotes
    Commercial Relationships    J.J. Pintor, INSPIRE PHARMACEUTICALS F; T. Pelaez, None; C.H.V. Hoyle, None; A. Peral, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4078. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      JJ Pintor, T Pelaez, CH V Hoyle, A Peral; Melatonin Analogues Modulate Rabbit Intraocular Pressure . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4078.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose:To determine the effects of melatonin receptor agonists and antagonists on intraocular pressure (IOP). Methods:Rabbits were kept under controlled 12 h/12 h light/ dark cycles. IOP was measured by means of a Tonopen contact tonometer. Agents were applied topically (10-12 M 10-2 M), unilaterally, to the cornea in volumes of 10 µL. The contralateral eye received the same volume of saline solution. Melatonin and its analogues, were used to establish dose-response curves. IOP was measured at 0.5, 1, 2, 3, 4, 5 and 6 hours after the application. Antagonist studies were performed by applying a dose of 5-MCA-NAT and graded doses of luzindole, DH-97, 4-P-PDOT and prazosin ranging from 10-12 M to 10-2 M 30 min before application of the agonist. Results:Melatonin, 2-Phe-melatonin, 6-Cl-melatonin, 2-I-melatonin, 5-MCA-NAT and N-acetylserotonin reduced IOP, the most effective compound being 5-MCA-NAT which reduced IOP to 65%. The pD2 values for the compounds were: melatonin, 7.860.30; 2-Phe-melatonin, 7.250.18; 6-Cl-melatonin, 7.580.05; 2-iodo-melatonin, 7.560.89; 5-MCA-NAT, 7.430.30; N-acetyl-melatonin, 7.970.30. Antagonists reversed the effect of melatonin and 5-MCA-NAT, among them prazosin presented a pA2 value of 8.490.17. Luzindole, DH-97 and 4-P-PDOT also antagonised the effects of melatonin, being active in the micromolar range. Conclusion:Melatonin receptor agonists, such as the selective MT3 receptor agonist 5-MCA-NAT may be useful for the treatment of those pathologies presenting with an elevated intraocular pressure such as glaucoma.

Keywords: 465 melatonin • 444 intraocular pressure • 541 receptors: pharmacology/physiology 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.